• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Cumulative total number of email subscribers at month end (1)(3)

Targeted listserve growth is 1.4% a month.

Dictionary: Medwatch Safety Alerts: Timely new safety information on all human medical products used in patient care, including prescription and over-the-counter drugs, biologicals and vaccines, medical devices such as implants, monitors, and stents, dietary supplements, and cosmetics. These alerts contain 'actionable' information that may impact both treatment and diagnostic choices for doctor and patient.

FDA Updates for Health Professionals: Recent announcements, medical product approvals, opportunities to comment on proposed rules, upcoming public meetings, and other information of interest to health professionals.

HIV/AIDS:Source for FDA HIV/AIDS related information on a variety of topics, including product approvals, significant labeling changes, safety warnings, notices of upcoming public meetings, proposed regulatory guidances, and opportunity to comment.

Hepatitis:Source for FDA Hepatitis related information on a variety of topics.

The more subscribers to the email listserves, the more stakeholders are being reached and being informed about the regulation of human medical products.

Fiscal Year - 2011

Skip graphic and jump to text data

Targeted listserve growth is 1.4% a month.

TimeTargetNumber
Oct 2010254,105254,429
Nov 2010257,663256,899
Dec 2010261,270256,814
Jan 2011264,927260,792
Feb 2011268,637269,178
Mar 2011272,398271,410
Apr 2011276,211274,610
May 2011280,078271,348
Jun 2011283,999268,338
Jul 2011287,975265,127
Aug 2011292,007264,181
Sep 2011292,007262,729

FY 2011 Overall: 262,729

Footnotes

  • (1) Full data against all listserves was not available for October 2009.
  • (2) Data was not available for October 2009.
  • (3) This measure will no longer be tracked after October 2011.

Cumulative number of email subscribers to MedWatch e-list at month end

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A171,987
Nov 2010N/A173,464
Dec 2010N/A173,096
Jan 2011N/A175,445
Feb 2011N/A176,755
Mar 2011N/A178,300
Apr 2011N/A180,068
May 2011N/A181,367
Jun 2011N/A185,771
Jul 2011N/A188,607
Aug 2011N/A190,548
Sep 2011N/A191,931

FY 2011 Overall: 191,931

Cumulative number of email subscribers to Health Professional Update e-list at month end

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A35,708
Nov 2010N/A36,017
Dec 2010N/A36,012
Jan 2011N/A36,585
Feb 2011N/A36,900
Mar 2011N/A37,082
Apr 2011N/A37,539
May 2011N/A37,987
Jun 2011N/A39,079
Jul 2011N/A39,702
Aug 2011N/A40,411
Sep 2011N/A41,333

FY 2011 Overall: 41,333

Cumulative number of email subscribers to Hepatitis e-list at month end (2)

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A16,779
Nov 2010N/A17,237
Dec 2010N/A17,515
Jan 2011N/A18,161
Feb 2011N/A18,623
Mar 2011N/A18,946
Apr 2011N/A19,464
May 2011N/A20,007
Jun 2011N/A23,335
Jul 2011N/A23,335
Aug 2011N/A22,063
Sep 2011N/A22,804

FY 2011 Overall: 22,804

Footnotes

  • (2) Data was not available for October 2009.

Cumulative number of email subscribers to HIV/AIDS e-list at month end (2)

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A29,955
Nov 2010N/A30,181
Dec 2010N/A30,191
Jan 2011N/A30,601
Feb 2011N/A30,788
Mar 2011N/A30,889
Apr 2011N/A31,239
May 2011N/A31,987
Jun 2011N/A34,343
Jul 2011N/A32,352
Aug 2011N/A33,310
Sep 2011N/A33,933

FY 2011 Overall: 33,933

Footnotes

  • (2) Data was not available for October 2009.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.